The relationship between cardiovascular disease risk prediction scores and vascular function and morphology in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 32, Issue 6, 2014, Pages 914-921

  Sandoo, Aamer ^a,b   Chanchlani, Neil ^a   Hodson, James ^d   Smith, Jacqueline P ^a   Douglas, Karen M ^a   Kitas, George D ^a,b,c  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Endothelium; Framingham; QRISK2; Rheumatoid arthritis

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QRISK SCORE; REYNOLDS RISK SCORE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; VASCULAR ENDOTHELIUM; ALGORITHM; ARTHRITIS, RHEUMATOID; BLOOD; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; COMPLICATION; DECISION SUPPORT SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; TIME;

AGED; ALGORITHMS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; DECISION SUPPORT TECHNIQUES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84925286260     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. KITAS GD, ERB N: Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 607-13.
2. SATTAR N, McINNES IB: Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Curr Opin Rheumatol 2005; 17: 286-92.
3. SCOTT IC, IBRAHIM F, JOHNSON D, SCOTT DL, KINGSLEY GH: Current limitations in the management of cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol 2012; 30: 228-32.
4. WILSON PW, D'AGOSTINO RB, LEVY D, BELANGER AM, SILBERSHATZ H, KANNEL WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
5. CONROY RM, PYORALA K, FITZGERALD AP et al.: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
6. RIDKER PM, BURING JE, RIFAI N, COOK NR: Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297: 611-9.
7. HIPPISLEY-COX J, COUPLAND C, VINOGRADOVA Y et al.: Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336: 1475-82.
8. MARADIT-KREMERS H, NICOLA PJ, CROWSON CS, BALLMAN KV, GABRIEL SE: Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52: 722-32.
9. RIDKER PM: High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 2003; 92: 17-22.
10. SANDOO A, VELDHUIJZEN van ZANTEN JJCS, METSIOS GS, CARROLL D, KITAS GD: The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010; 4: 302-12.
11. CORRADO E, RIZZO M, COPPOLA G, MURATORI I, CARELLA M, NOVO S: Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis 2008; 19: 139-44.
12. LERMAN A, ZEIHER AM: Endothelial function: cardiac events. Circulation 2005; 111: 363-8.
13. SANDOO A, KITAS GD, CARROLL D, VELDHUIJZEN van ZANTEN J: The role of inflammation & cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther 2012; 14: R117.
14. ZAMPELI E, PROTOGEROU A, STAMATELOPOULOS K et al.: Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther 2012; 14: R44.
15. MITCHELL GF, VITA JA, LARSON MG et al.: Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation 2005; 112: 3722-8.
16. MITCHELL GF, PARISE H, VITA JA et al.: Local Shear Stress and Brachial Artery Flow-Mediated Dilation: The Framingham Heart Study. Hypertension 2004; 44: 134-9.
17. WITTE DR, WESTERINK J, de KONING EJ, van der GRAAF Y, GROBBEE DE, BOTS ML: Is the association between flow-mediated dilation and cardiovascular risk limited to lowrisk populations? J Am Coll Cardiol 2005; 45: 1987-93.
18. PANOULAS VF, DOUGLAS KM, MILIONIS HJ et al.: Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1477-82.
19. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
20. PREVOO ML, Van't HOF MA, KUPER HH, Van LEEUWEN MA, van de PUTTE LB, van RIEL PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
21. WILSON PWF, D'AGOSTINO RB, LEVY D, BELANGER AM, SILBERSHATZ H, KANNEL WB: Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
22. PETERS MJL, SYMMONS DPM, McCAREY D et al.: EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
23. TURNER J, BELCH JJ, KHAN F: Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 2008; 18: 109-16.
24. CORRETTI MC, ANDERSON TJ, BENJAMIN EJ et al.: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65.
25. SIDHU JS, NEWEY VR, NASSIRI DK, KASKI JC: A rapid and reproducible on line automated technique to determine endothelial function. Heart 2002; 88: 289-92.
26. TOUBOUL PJ, HENNERICI MG, MEAIRS S et al.: Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012; 34: 290-6.
27. PIGNOLI P, TREMOLI E, POLI A, ORESTE P, PAOLETTI R: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
28. LIANG Q, WENDELHAG I, WIKSTRAND J, GUSTAVSSON T: A multiscale dynamic programming procedure for boundary detection in ultrasonic artery images. IEEE Trans Med Imaging 2000; 19: 127-42.
29. SANDOO A, CHANCHLANI N, HODSON J, SMITH JP, DOUGLAS KM, KITAS GD: Classical Cardiovascular Disease Risk Factors Associate with Vascular Function and Morphology in Rheumatoid Arthritis: a six year prospective study. Arthritis Res Ther 2013; 15: R203.
30. HASHIMOTO M, KOZAKI K, ETO M et al.: Association of coronary risk factors and endothelium-dependent flow-mediated dilatation of the brachial artery. Hypertens Res 2000; 23: 233-8.
31. SANDOO A, PANOULAS VF, TOMS TE et al.: Anti-TNF-alpha therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis. J Hum Hypertens 2011; 25: 699-702.
32. SANDOO A, van ZANTEN JJ, TOMS TE, CARROLL D, KITAS GD: Anti-TNF-alpha therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study. BMC Musculoskelet Disord 2012; 13: 127.
33. RIDKER PM, HENNEKENS CH, BURING JE, RIFAI N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
34. LIBBY P, RIDKER PM: Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004; 116 (Suppl. 6A): 9S-16S.
35. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, PINEIRO A, GARCIA-PORRUA C, TESTA A, LLORCA J: High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1219-23.
36. STAMATELOPOULOS KS, KITAS GD, PAPAMICHAEL CM et al.: Atherosclerosis in Rheumatoid Arthritis Versus Diabetes. A Comparative Study. Arterioscler Thromb Vasc Biol 2009; 29: 1702-8.
37. SANDOO A, VELDHUIJZEN van ZANTEN JJCS, METSIOS GS, CARROLL D, KITAS GD: Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology 2011; 50: 2125-39.
38. McEWAN P, WILLIAMS JE, GRIFFITHS JD et al.: Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet Med 2004; 21: 318-23.
39. CHUNG CP, OESER A, AVALOS I, RAGGI P, STEIN CM: Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Lupus 2006; 15: 562-9.
40. KEREKES G, SZEKANECZ Z, DER H et al.: Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008; 35: 398-406.
41. SOLTESZ P, DER H, KEREKES G et al.: A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol 2009; 28: 655-62.
42. CHUNG CP, OESER A, AVALOS I et al.: Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2006; 8: R186.
43. CROWSON CS, GABRIEL S: Towards improving cardiovascular risk management in patients with rheumatoid arhthritis: the need for accurate risk assessment. Ann Rheum Dis 2011; 70: 719-21.
44. MARADIT-KREMERS H, CROWSON CS, NICOLA PJ et al.: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005; 52: 402-11.
45. HOLMQVIST ME, WEDREN S, JACOBSSON LT et al.: Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 2010; 268: 578-85.
46. FRANKLIN J, FARRAGHER TM, LUNT M et al.: Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis. Ann Rheum Dis 2010; 69: 1660-4.
47. ROSALES-ALEXANDER JL, SALVATIERRA J, LLORCA J et al.: Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index. Clin Exp Rheumatol 2014; 32: 237-42.
48. GOMEZ-VAQUERO C, CORRALES A, ZACARIAS A et al.: SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis. Arthritis Res Ther 2013; 15: R91.
49. GONZALEZ-JUANATEY C, LLORCA J, MARTIN J, GONZALEZ-GAY MA: Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis. Semin Arthritis Rheum 2008; 385: 366-71.
50. STOKES KY, GRANGER DN: The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia? J Physiol 2005; 562: 647-53.